Gastrointestinal Stromal Neoplasms research hub

A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)

This study is for adults with a type of cancer called GIST in their digestive system that has spread or can't be removed by surgery. It compares a new medicine, velzatinib, with the usual treatment, imatinib, to see if it works better at slowing the cancer's growth and is safe.